BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16036687)

  • 1. Science, faith and AIDS: the battle over harm reduction.
    Wynia MK
    Am J Bioeth; 2005; 5(2):3-4. PubMed ID: 16036687
    [No Abstract]   [Full Text] [Related]  

  • 2. "Harm reduction--coming of age": a local movement with global impact.
    Stimson GV
    Int J Drug Policy; 2007 Mar; 18(2):67-9. PubMed ID: 17689346
    [No Abstract]   [Full Text] [Related]  

  • 3. Peer counseling perspectives. Harm reduction all around.
    Hemphill ML
    Surviv News (Atlanta Ga); 2005; 16(6):7. PubMed ID: 16388537
    [No Abstract]   [Full Text] [Related]  

  • 4. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring effectiveness of needle and syringe exchange programs for prevention of HIV among injecting drug users: Response to Amundsen.
    Maher L; Iversen J; Kaldor J
    Addiction; 2006 Dec; 101(12):1834-6. PubMed ID: 17156184
    [No Abstract]   [Full Text] [Related]  

  • 6. The Latin American harm reduction network (RELARD): successes and challenges.
    Bueno R
    Int J Drug Policy; 2007 Mar; 18(2):145-7. PubMed ID: 17689358
    [No Abstract]   [Full Text] [Related]  

  • 7. Failed drug policies in the United States and the future of AIDS: a perfect storm.
    Drucker E
    J Public Health Policy; 2012 Aug; 33(3):309-16. PubMed ID: 22895500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thinking ethically about needle and syringe programs.
    Kleinig J
    Subst Use Misuse; 2006; 41(6-7):815-25. PubMed ID: 16809168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islam and harm reduction.
    Kamarulzaman A; Saifuddeen SM
    Int J Drug Policy; 2010 Mar; 21(2):115-8. PubMed ID: 20006483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
    Elliott R; Csete J; Wood E; Kerr T
    Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of HIV/AIDS among injection drug users: the theory and science of public health and criminal justice approaches to disease prevention.
    Gostin LO; Lazzarini Z
    Emory Law J; 1997; 46(2):587-696. PubMed ID: 11769762
    [No Abstract]   [Full Text] [Related]  

  • 13. Syringe exchange.
    Jacobs R; Toynton P
    N J Med; 2003 Sep; 100(9 Suppl):55-9; quiz 79-80. PubMed ID: 14556605
    [No Abstract]   [Full Text] [Related]  

  • 14. The Harm Reduction Coalition.
    Clear A; Springer E; Lanier C
    Newsline People AIDS Coalit N Y; 1998 Jun; ():27-34. PubMed ID: 11367469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harm reduction actions as a health care construction process at a public health center in Rosario, Argentina.
    Lavarello D; Lottero M; Chavero M; Toledo A; EspĂ­nola M; Gerlero S; Liborio M
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S353-7. PubMed ID: 14648446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction and control of HIV in IDUs in France.
    Carrieri MP; Spire B
    Lancet; 2008 Aug; 372(9637):448. PubMed ID: 18692713
    [No Abstract]   [Full Text] [Related]  

  • 17. The transition to harm reduction: understanding the role of non-governmental organisations in Malaysia.
    Narayanan S; Vicknasingam B; Robson NM
    Int J Drug Policy; 2011 Jul; 22(4):311-7. PubMed ID: 21300533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The place of supervised injecting facilities within harm reduction: evidence, ethics and policy.
    Fry CL; Cvetkovski S; Cameron J
    Addiction; 2006 Apr; 101(4):465-7. PubMed ID: 16548922
    [No Abstract]   [Full Text] [Related]  

  • 19. NIH report.
    Makulowich GS
    AIDS Patient Care STDS; 1998 Feb; 12(2):151. PubMed ID: 11361922
    [No Abstract]   [Full Text] [Related]  

  • 20. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.